期刊文献+

氟西汀对APP/PS1双转基因阿尔茨海默病模型小鼠记忆能力的改善作用及其机制 被引量:7

Study on the Mechanism and Improvement of APP/PS1 Double Transgenic AD Mice's Learning and Memory by Fluoxetine
原文传递
导出
摘要 本研究初步探讨氟西汀(Fluoxetine)改善淀粉样蛋白前体蛋白(β-amyloid precursor protein,APP)/早老素1(presenilin 1,PS1)双转基因阿尔茨海默病(Alzheimer's disease,AD)模型小鼠的学习记忆能力及可能机制。采用APP/PS1双转基因AD模型雄性小鼠,随机分成氟西汀处理组(FLU)和生理盐水组(NS),分别给予氟西汀10 mg·kg-1·d-1和等量生理盐水腹腔注射60 d。药物处理后行水迷宫检测小鼠学习记忆能力,采用尼氏染色观察海马神经元数量的变化,用免疫组化检测海马的Ach E的变化。水迷宫定位航行实验结果显示氟西汀组较生理盐水组的逃避潜伏期、总路程明显缩短(p<0.05),游泳速度无明显差异;空间探索实验氟西汀组穿台次数较生理盐水组明显增加(p<0.05)。尼氏染色结果显示氟西汀组在CA1区神经元数量和生理盐水组无显著性差异(p>0.05),氟西汀组在DG区神经元数量比生理盐水组明显增多(p<0.05)。乙酰胆碱酯酶(Ach E)免疫组化染色结果显示氟西汀组在海马CA1、DG区乙酰胆碱酯酶表达量较生理盐水组明显减少(p<0.05)。穿台次数与CA1和DG区Ach E的表达量之间的有显著性的相关性(CA1区r=-0.791,p=0.002,DG区r=-0.839,p=0.001)。本研究结果提示氟西汀可通过减少AD小鼠海马DG区神经元的数量丢失和下调AD小鼠海马区Ach E表达量而改善AD模型小鼠的空间学习记忆能力。 To discuss whether Fluoxetine improve the ability of learning and space learning memory of APP/PS12×Tg Alzheimer's Disease Mice. Further to discuss whether the protective effect of Fluoxetine through decreased the expression of Ach E and reduced the loss of neurons in hippocampus. Experimental animals were divided into two groups: APP/PS1 AD model injection of Fluoxetine(FLU) group(n=6), APP/PS1 AD model saline group(NS)(n=6). After intraperitoneal injection of fluoxetine 10 mg·kg-1·d-1for 60 days, Morris water maze test was used to assess the cognitive behavioristics in each group. Nissl staining was applied to quantify neurons in hippocampus.Immunohistochemistrical staining was use to analyze the expression of Ach E in hippocampus. In Morris water maze place navigation trial, the FLU group reduce the time of latency and cumulative distance significantly compared with the NS group(p<0.05, n=6). There was no significant difference on swimming speed between the two group. In spatial probe trial, the FLU significantly improved the number of crossing the plate. Immunohistochemistry staining of the Ach E shows that positive intensity in FLU group are less than NS group(p<0.05, n=6). Nissl staining shows that hippocampus neurons in FLU group were significantly more than that of NS group(p<0.05, n=6). The number of crossing the plate was negatively related to the IOD of Immunohistochemistry staining of the Ach E in area CA1(r=-791, p=0.002) and DG(r=-70.839, p=0.001) of hippocampus. Long-term administration of fluoxetine significantly decreased AD model mice Ach E expression in hippocampus, reduced the loss of neurons in hippocampus and improved the ability of learning and memory in APP/PS1 2×Tg Alzheimer's Disease Mice.
出处 《基因组学与应用生物学》 CAS CSCD 北大核心 2015年第8期1587-1593,共7页 Genomics and Applied Biology
基金 国家自然科学基金(81171238 31271288)资助
关键词 阿尔茨海默病 氟西汀 乙酰胆碱酯酶 MORRIS水迷宫 Alzheimer's disease Fluoxetine Acetylcholinesterase Morris water maze
  • 相关文献

参考文献18

  • 1Braak H,Feldengut S,Del Tredici K.Pathogenesis and prevention of Alzheimer’’s disease:when and in what way does the pathological process begin?. Nervenarzt . 2013
  • 2Gatz Margaret,Reynolds Chandra A,Fratiglioni Laura,Johansson Boo,Mortimer James A,Berg Stig,Fiske Amy,Pedersen Nancy L.Role of genes and environments for explaining Alzheimer disease. Archives of General Psychiatry . 2006
  • 3Waring Stephen C,Rosenberg Roger N.Genome-wide association studies in Alzheimer disease. Archives of Neurology . 2008
  • 4P. Tiraboschi,L.A. Hansen,L.J. Thal,J. Corey-Bloom.??The importance of neuritic plaques and tangles to the development and evolution of AD(J)Neurology . 2004 (11)
  • 5Ron Brookmeyer,Elizabeth Johnson,Kathryn Ziegler-Graham,H. Michael Arrighi.??Forecasting the global burden of Alzheimer’s disease(J)Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association . 2007 (3)
  • 6Renaud Vandenbosch,Laurence Borgs,Pierre Beukelaers,Shibeshih Belachew,Gustave Moonen,Laurent Nguyen,Brigitte Malgrange.Adult Neurogenesis and the Diseased Brain. Current Medicinal Chemistry . 2009
  • 7Nagahara Alan H,Merrill David A,Coppola Giovanni,Tsukada Shingo,Schroeder Brock E,Shaked Gideon M,Wang Ling,Blesch Armin,Kim Albert,Conner James M,Rockenstein Edward,Chao Moses V,Koo Edward H,Geschwind Daniel,Masliah Eliezer,Chiba Andrea A.Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer’s disease. Nature Medicine . 2009
  • 8Dickey Chad A,Loring Jeanne F,Montgomery Julia,Gordon Marcia N,Eastman P Scott,Morgan Dave.Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice. The Journal of neuroscience : the official journal of the Society for Neuroscience . 2003
  • 9R. C. Petersen,B. Caracciolo,C. Brayne,S. Gauthier,V. Jelic,L. Fratiglioni.??Mild cognitive impairment: a concept in evolution(J)J Intern Med . 2014 (3)
  • 10李航,钟志鸿,杨进,董靖.海马突触可塑性与创伤后应激障碍(PTSD)相关研究[J].基因组学与应用生物学,2015,34(3):658-662. 被引量:11

二级参考文献2

共引文献15

同被引文献51

  • 1王虎平,邢喜平,张雯娟,吴红彦.逍遥散对阿尔茨海默病模型小鼠学习记忆及神经递质的影响[J].中国老年学杂志,2014,34(9):2468-2470. 被引量:15
  • 2Castellani R.J., Rolston R.K., and Smith M.A., 2010, Alzheimer disease, Dis. Mon., 56(9): 484-546.
  • 3Doraiswamy P.M., Krishnan K.R., Oxman T., Jenkyn L.R., Coffey D.J., Burt T., and Clary C.M., 2003, Does antidepressant therapy improve cognition in elderly depressed patients, J. Gerontol A Biol. Sci. Med. Sci., 58(12): M1137-M1144.
  • 4Felsenstein K.M., Candelario K.M., Steindler D.A., and Borchelt D.R., 2014, Regenerative medicine in Alzheimer's disease, Transl. Res., 163(4): 432-438.
  • 5Ghosh R., Gupta R., Bhatia M.S., Tripathi A.K., and Gupta L.K., 2015, Comparison of efficacy, safety and brain derived neurotrophic factor (BDNF) levels in patients of major depressive disorder, treated with fluoxetine and desvenlafaxine, Asian Journal of Psychiatry, 18:37-41.
  • 6Hejun L., and Bai H., 2014, Effect of brain derived neurotrophic factor in Alzheimer disease, Electronic Edition, 21.
  • 7Huang Y., and Mucke L., 2012, Alzheimer mechanisms and therapeutic strategies, Cell, 148(6): 1204-1222.
  • 8Kim H.J., Kim W., and Kong S.Y., 2013, Antidepressants for neuro-regeneration from depression to Alzheimers disease, Archives of Pharmacal Research, 36(11): 1279- 1290.
  • 9Marlatt M.W., Lucassen P.J., and van Praag H., 2010, Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice, Brain Res., 1341:93-99.
  • 10Waite L.M., 2015, Treatment for Alzheimer's disease has anything changed? Aust.Prescr., 38(2): 60-63.

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部